Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
4,837 Shares in ResMed Inc. $RMD Acquired by Runnymede Capital Advisors Inc.
Runnymede Capital Advisors Inc. has acquired a new stake of 4,837 shares in ResMed Inc. (NYSE:RMD) during Q4, valued at approximately $1.165 million. This comes as institutional ownership in ResMed stands at about 54.98%, with various other firms adjusting their positions. While analysts maintain a “Moderate Buy” rating for ResMed with a consensus target price of $299.27, insider selling has occurred, with director Peter C. Farrell and CEO Michael J. Farrell selling shares recently.